Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This Phase III study will assess whether AZD7442 (a combination of 2 mAbs) can safely treat outpatient adults with COVID-19 and prevent either severe COVID-19 or death.
Epistemonikos ID: 37006bc26446c8ed100c79d6781f5ee0863a60c8
First added on: Jan 26, 2021